Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for chronic post-traumatic peripheral neuropathic pain (double-blind, placebo-controlled)
2012-003304-12Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Peripheral neuropathic pain and Neuralgia comparing Pregabalin BID with Placebo BID (2 arms). Primary endpoint: Primary Efficacy Endpoint. Started Jan 2013; status: completed.
02
Drugs
pregabalin
03
Conditions
Peripheral neuropathic painNeuralgia
Beyond the preview
Go deeper on 2012-003304-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003304-12.